SiPhox Health
SiPhox Health is a Burlington, MA-based diagnostics company (founded 2020 by MIT researchers) that operates an at-home blood biomarker testing platform built on proprietary silicon photonics and the painless EasyDraw collection kit, serving health-conscious consumers, longevity clinics, employers, and research organizations through DTC subscriptions and a white-label API.
- Company typePrivate
- Founded2020
- HeadquartersBurlington, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What SiPhox Health does
SiPhox Health is a Burlington, Massachusetts-based health diagnostics company founded in 2020 by two MIT researchers that builds at-home blood biomarker testing infrastructure using a proprietary silicon photonics platform that integrates photonics, electronics, and microfluidics on a chip. Its core consumer offering, EasyDraw, is a painless upper-arm blood collection kit that ships to members, with samples processed at CLIA- and CAP-accredited labs and results delivered (typically within 7–10 days) through an AI-powered dashboard featuring the Sai conversational assistant, BioAge calculation, optimal-range analysis, and personalized supplement and lifestyle action plans.
The company operates a modular product architecture: members subscribe to flexible-cadence testing (monthly, quarterly, or every 6 months) and select from purpose-built panels including Longevity Essentials, Heart & Metabolic, Hormone Focus, Thyroid Focus, GLP Optimization (for patients on GLP-1 therapies), and the comprehensive Ultimate 360 (up to 59 biomarkers). An investigational in-home device, SiPhox Home, extends the same silicon photonics approach to deliver lab-quality results in 60 minutes and is positioned for FDA-cleared consumer rollout, targeting cardio, metabolic, inflammation, women's health, and oncology screening applications.
Commercially, SiPhox combines a direct-to-consumer e-commerce channel through siphoxhealth.com with a B2B white-label and API partner program serving longevity clinics, wellness brands, wellness retreats, employers, coaches, and research/pharma organizations. Strategic distribution has been amplified by a 2026 Samsung partnership integrating SiPhox into Samsung Health and SmartThings, and the company has raised approximately $32.8 million across seed, Series A, and follow-on rounds led by Intel Capital with participation from Khosla Ventures, Y Combinator, and a broader syndicate.
SiPhox Health firmographics
Firmographics- Name
- SiPhox Health
- Legal name
- SiPhox, Inc.
- Website
- https://siphoxhealth.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SiPhox Health is a Burlington, MA-based diagnostics company (founded 2020 by MIT researchers) that operates an at-home blood biomarker testing platform built on proprietary silicon photonics and the painless EasyDraw collection kit, serving health-conscious consumers, longevity clinics, employers, and research organizations through DTC subscriptions and a white-label API.
- Ownership category
- akta.pro rank
SiPhox Health industry classification
Industry- Product category
- At-home blood diagnostic testing
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)
Keywords
Where SiPhox Health is headquartered
LocationHeadquarters
- HQ city
- Burlington
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SiPhox Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Subscription Membership: Recurring subscription model with membership fee covering testing panels, dashboard access, AI insights, and member benefits. Flexible testing cadence - users test monthly, quarterly, or every 6 months. Membership starts at $99-$124 per test with shipping. Cancel anytime.
- Premium Panel Upgrades: Additional fees for enhanced biomarker panels: GLP Monitoring Panel (+$75), Wellness+ (+$40), Wellness & Hormone (+$75), Wellness & Thyroid (+$75), Ultimate 360 (+$125). Upsell opportunity within subscription.
- White-Label Partnership Licensing: B2B licensing of testing infrastructure, dashboard, and API to longevity clinics, wellness brands, employers, and healthcare providers. Partners can co-brand or integrate via API for custom experiences.
- Partner Integrations and Add-ons: Commission-based partnerships with Prenuvo (Whole Body MRI), health coaching sessions, gut microbiome testing, and allergy panels offered as exclusive member benefits. Company earns referral fees or negotiated rates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Longevity Essentials - Core biomarker panel (24-29 biomarkers) |
| Subscription | Pay-as-you-go | Heart & Metabolic Panel - 26 biomarkers focused on cardiovascular health |
| Subscription | Pay-as-you-go | Hormone Focus Panel - 14 biomarkers for hormonal health |
| Subscription | Pay-as-you-go | Thyroid Focus Panel - 21 biomarkers for thyroid assessment |
| Subscription | Pay-as-you-go | GLP Monitoring Panel - 40+ biomarkers for GLP therapy tracking |
| Subscription | Pay-as-you-go | Ultimate 360 - Comprehensive panel with 59 biomarkers |
| Subscription | Pay-as-you-go | Add-on Panels (Wellness+, Hormone+, Metabolic+, Thyroid+) |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
SiPhox Health product offering
Product offeringCore offering
SiPhox Health operates an at-home blood biomarker testing service in which members collect a blood sample via the painless EasyDraw upper-arm device, mail it to CLIA/CAP-accredited labs, and receive results in 7-10 days through an AI-powered dashboard (Sai assistant) with personalized action plans. The offering is sold primarily as a consumer membership with flexible testing cadence ($99-$199 per test) and is also licensed as a white-label platform/API to longevity clinics, wellness brands, employers, and research organizations. An investigational SiPhox Home silicon photonics device is in development to deliver lab-quality results in 60 minutes.
Product overview
SiPhox Health operates as a platform-plus-modules architecture built around its EasyDraw at-home blood testing platform and the upcoming SiPhox Home silicon photonics device. The core offering is a membership-based service ($99-199/month) providing painless at-home biomarker testing with AI-powered insights. Members choose from specialized program panels: Longevity Essentials (included), Thyroid Focus, Hormone Focus, Heart & Metabolic, GLP Optimization (for medication monitoring), and Ultimate 360 (comprehensive 59-biomarker panel). All results are delivered through a unified dashboard featuring the Sai AI assistant for personalized recommendations and supplement optimization. The company also offers a Partner Platform enabling white-label or API integration for healthcare providers, wellness brands, and employers.
Differentiator
Problem solved
Functional benefit
Brands
- EasyDraw: Painless upper-arm blood collection device for at-home biomarker testing
- SiPhox Home
- Ultimate 360
- Longevity Essentials
- Heart & Metabolic
- Hormone Focus
- Thyroid Focus
- GLP Optimization
Products and services
- EasyDraw At-Home Blood Testing Platform
- Ultimate 360 Program
- GLP Optimization Panel
- SiPhox Home Device
- Partner Platform & White-Label Testing Solutions
Quantifiable outcome
- 50,000+ individuals using the platform for health tracking
- +4 more outcomes
Companies that use SiPhox Health
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
SiPhox Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability7 records
Feature5 records
SiPhox Health partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered flagship, minor and core.
- SamsungflagshipPartnership announced at VivaTech 2026 in Paris. SiPhox Health is one of three health startups (alongside Generation Lab and Xealth) in Samsung's connected care vision. Integrates with Samsung Health (77M MAU) and SmartThings (460M devices) ecosystem to enable hospital-grade blood testing at home. Samsung opened Samsung Health SDK Suite to developers.
- Generation LabminorHealth startup partner in Samsung's connected care ecosystem announcement at VivaTech 2026. Co-showcased with SiPhox as part of Samsung's preventive health platform vision.
- XealthminorHealth startup partner in Samsung's connected care ecosystem announcement at VivaTech 2026. Panelists discussed integration with Samsung's ecosystem for services ranging from biological age tracking to hospital-grade blood testing.
- PrenuvocoreExclusive member-only partnership offering Prenuvo Whole Body MRI scans at discounted prices to SiPhox members. Partnership provides additional health insights (full-body MRI) that complement biomarker data.
- Beluga Health P.A. of FloridacoreIndependent healthcare provider group providing telehealth clinical services for SiPhox Heart and Metabolic Program members seeking medication management. Clinicians review questionnaire and test results, establish patient-physician relationship.
- Million markerminorPartner brand shown in SiPhox Health partner logo section. Nature of partnership (reseller, referral, integration) not fully specified.
- MiraminorPartner brand shown in SiPhox Health partner logo section. Wellness brand potentially integrating or reselling SiPhox testing services.
- PeopleScienceminorPartner brand shown in SiPhox Health partner logo section. Nature of partnership (reseller, referral, integration) not fully specified.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
SiPhox Health competitors and assessment
Company assessmentEmerging players
- Viome: At-home microbiome and blood transcriptomics testing with personalized nutrition recommendations. Comparable at-home collection + AI-powered wellness insights motion.
- Prenuvo: Whole-body MRI preventive scanning service that already has an exclusive member-discount partnership with SiPhox. Overlaps on preventive-health-conscious consumer target market.
- Levels Health: Continuous glucose monitoring-driven metabolic health platform with overlapping biohacker/longevity consumer base. Adjacent rather than direct overlap, with CGM vs blood biomarker testing.
Direct peers
- Everlywell: At-home collection-based health testing brand offering panels for hormones, thyroid, metabolism and more with physician-reviewed results. Competes directly in D2C lab testing with overlapping panel structures.
- Function Health: Direct D2C competitor offering comprehensive at-home blood biomarker testing (100+ markers) with physician review and personalized action plans. Closest comparable in membership-based preventive blood testing model.
- InsideTracker: Personalized health analytics platform offering at-home blood testing with biomarker analysis and science-based recommendations for nutrition, exercise, and supplementation. Directly competes in the longevity/biohacker preventive testing niche.
- LetsGetChecked: At-home health testing company with finger-prick/venous sample collection connected to physician-reviewed results and prescription services. Comparable D2C diagnostics model.
- Thorne: Supplement + at-home testing company with health testing kits combined with personalized supplement recommendations. Direct overlap in the "test-then-act" wellness consumer motion.
Broad incumbents
- Labcorp: Major clinical laboratory network with at-home and direct-to-consumer testing services (e.g., Labcorp OnDemand). Establishes the standard against which SiPhox validates accuracy (per their comparison claims).
- Quest Diagnostics: Largest clinical laboratory services company in the US, providing blood testing through physician orders and direct consumer offerings (e.g., Quest's Blueprint). Broad incumbent competing for the same biomarker testing demand.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SiPhox Health social profiles
Digital presenceSiPhox Health compliance and trust
Trust signalCompliance4 records
SiPhox Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
SiPhox Health leadership team
Management profileNumber of profiles
Profiles9 records
SiPhox Health funding detail
Funding detailFunding overview
Funding rounds5 records
Investors18 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SiPhox Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SiPhox Health
What does SiPhox Health do?
SiPhox Health operates an at-home blood biomarker testing service in which members collect a blood sample via the painless EasyDraw upper-arm device, mail it to CLIA/CAP-accredited labs, and receive results in 7-10 days through an AI-powered dashboard (Sai assistant) with personalized action plans. The offering is sold primarily as a consumer membership with flexible testing cadence ($99-$199 per test) and is also licensed as a white-label platform/API to longevity clinics, wellness brands, employers, and research organizations. An investigational SiPhox Home silicon photonics device is in development to deliver lab-quality results in 60 minutes.
Is SiPhox Health a public or private company?
SiPhox Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was SiPhox Health founded?
SiPhox Health was founded in 2020. It employs 11 to 50 people.
Where is SiPhox Health based?
SiPhox Health is headquartered in Burlington, United States, in the North America region.
How does SiPhox Health make money?
Four revenue lines are on record. Subscription Membership is the primary driver. The others are premium Panel Upgrades, white-Label Partnership Licensing and partner Integrations and Add-ons.
Who are SiPhox Health's main competitors?
Emerging players on record are Viome, Prenuvo and Levels Health. Direct peers are Everlywell, Function Health, InsideTracker, LetsGetChecked and Thorne. Broad incumbents are Labcorp and Quest Diagnostics.
Does SiPhox Health have an API?
Yes. SiPhox offers an API for partners to integrate blood test results into their own platforms. Partners can choose between a co-branded dashboard or seamless API integration. The API provides customizable software for reviewing and displaying test results, enabling structured and actionable health data to be delivered through partner platforms.
What industry is SiPhox Health in?
SiPhox Health's product category is At-home blood diagnostic testing. Its primary akta.pro industry code is HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home). Its NAICS code is 6215 and its SIC code is 8071.